MedTrace Logo

Comparative Evaluation of Antimicrobial Efficacy, Clinical and Radiographic Success of Calcium Hydroxide, Chlorhexidine, and Modified Triple Antibiotic Paste in Different Combination Forms As Intracanal Medicaments Against Enterococcus Faecalis in Primary Teeth

NCT06625645 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2024-10-17

No results posted yet for this study

Summary

Comparing between different intracanal medications with different combination forms of Modified Triple Antibiotic Paste, Calcium Hydroxide and Chlorehexidine, regarding antimicrobial efficacy through bacterial reduction count of enterococcus Faecalis and regarding clinical and radiographic success in non vital primary teeth necessitating pulpectomy with follow up time 1 year.

Conditions

  • Apical Periodontitis
  • Necrotic Primary Molars
  • Periapical Pathosis of Primary Molars

Interventions

COMBINATION_PRODUCT

Modified triple antibiotic paste (TAP) mixed with chlorehexidine

M-TAP with CHX 2%

COMBINATION_PRODUCT

Modified Triple Antibiotic Paste mixed with saline

M-TAP mixed with saline

COMBINATION_PRODUCT

Calcium Hydroxide mixed with chlorohexidine Intracanal medication

calcium hydroxide powder mixed with CHX 2% solution as intracanal medication

COMBINATION_PRODUCT

calcium hydroxide mixed with saline as intracanal medication

calcium hydroxide mixed with saline as intracanal medication for necrotic primary molars

Sponsors & Collaborators

  • Mahy Abdel Raouf Aly Kamar

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2025-05-01
Completion
2026-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06625645 on ClinicalTrials.gov